FLORTAUCIPIR F-18

Details

Stereochemistry	ACHIRAL
Molecular Formula	C16H10FN3
Molecular Weight	262.2716
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[18F]C1=NC=C(C=C1)C2=CC3=C(C=C2)C4=C(N3)C=CN=C4

InChI

InChIKey=GETAAWDSFUCLBS-SJPDSGJFSA-N

InChI=1S/C16H10FN3/c17-16-4-2-11(8-19-16)10-1-3-12-13-9-18-6-5-14(13)20-15(12)7-10/h1-9,20H/i17-1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23411393 | https://www.ncbi.nlm.nih.gov/pubmed/28219440 | http://adisinsight.springer.com/drugs/800039440

Flortaucipir (18F-AV-1451, also known as 18F-T807) is a highly selective positron emission tomography (PET) imaging agent targeting paired helical filament (PHF)-tau in the brain. This tracer is studying for clinical assessment in patients with various tauopathies, including Alzheimer's disease, as well as in healthy subjects.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Microtubule-associated protein tau 4 Target ID: CHEMBL1293224 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28219440 \| https://www.ncbi.nlm.nih.gov/pubmed/23411393	Binding Agent 1064		14.6 nM [Kd]

Conditions

Condition	Modality	Targets	Highest Phase	Product
Alzheimer’s disease 272 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23411393 https://www.ncbi.nlm.nih.gov/pubmed/28219440	Diagnostic		Phase III 656	Unknown Approved Use Unknown

PubMed

Title	Date	PubMed
Synthesis and quality control of [(18) F]T807 for tau PET imaging.	2016 Aug	27427174
Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease.	2016 Oct	27151986
Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia.	2017 Apr-Jun	28394771
Quantification of Tau Load Using [(18)F]AV1451 PET.	2017 Dec	28374171
Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.	2017 Dec 1	28973551
Tau PET imaging: present and future directions.	2017 Feb 20	28219440
Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.	2017 Jul 1	28558094
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.	2017 Mar 1	28077397
(18)F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease.	2018 Feb	28747523

Patents

Sample Use Guides

In Vivo Use Guide

Flortaucipir PET images were acquired for 20 min, as four 5-min frames, beginning 80 min after injection of 370 MBq flortaucipir. On a separate day, subjects underwent a florbetapir PET scan for 10 min, as two 5-min frames, beginning 50 min after injection of 370 MBq florbetapir F18.

Route of Administration: Parenteral

In Vitro Use Guide

Unknown

Name

Type

Language

FLORTAUCIPIR F-18

Common Name

English

Flortaucipir (18F) [WHO-DD]

Common Name

English

FLORTAUCIPIR F 18

Official Name

English

LY3191748

Code

English

7-(6-(F-18)FLUOROPYRIDIN-3-YL)-5H-PYRIDO(4,3-B)INDOLE

Common Name

English

T807 F-18

Code

English

FLORTAUCIPIR F 18 [USAN]

Common Name

English

(F-18)T807

Code

English

AV-1451 F-18

Code

English

[18F]FLORTAUCIPIR

Common Name

English

TAUVID

Brand Name

English

18F-AV-1451

Code

English

flortaucipir (¹⁸F) [INN]

Common Name

English

T-807 F-18

Code

English

FLORTAUCIPIR F18 [MI]

Common Name

English

FLORTAUCIPIR F-18 [ORANGE BOOK]

Common Name

English

FLORTAUCIPIR (18F)

Official Name

English

LY-3191748

Code

English

Code System Code Type Description

PUBCHEM

70957463

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

DRUG BANK

DB14914

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

WIKIPEDIA

Flortaucipir (18F)

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

MERCK INDEX

m12220

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

USAN

CD-33

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

CAS

1522051-90-6

Created by admin on Sat Dec 16 09:53:51 GMT 2023 , Edited by admin on Sat Dec 16 09:53:51 GMT 2023

PRIMARY

EPA CompTox

DTXSID001027893

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

INN

10203

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

SMS_ID

100000178384

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

DAILYMED

T1JP1KYU9O

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

ChEMBL

CHEMBL3546271

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

FDA UNII

T1JP1KYU9O

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

RXCUI

2372689

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

NCI_THESAURUS

C171887

Created by admin on Sat Dec 16 09:53:52 GMT 2023 , Edited by admin on Sat Dec 16 09:53:52 GMT 2023

PRIMARY

ACTIVE MOIETY


					T1JP1KYU9O

FLORTAUCIPIR F-18

Details

SMILES

InChI

DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/23411393 | https://www.ncbi.nlm.nih.gov/pubmed/28219440 | http://adisinsight.springer.com/drugs/800039440

CNS Activity

Originator

Approval Year

Targets

Conditions

Approved Use

PubMed

Patents

Sample Use Guides

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23411393 | https://www.ncbi.nlm.nih.gov/pubmed/28219440 | http://adisinsight.springer.com/drugs/800039440